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Introduction
Recurrent aphthous stomatitis (RAS) refers to recurring 
ovoid or round ulcers with yellow base and erythema in 
the surrounding tissue.
1
 It is the most common painful 
ulcerative disease of oral mucosa happening in about 
20% of people.
2,3
 Even though the exact pathology is yet 
to be elucidated, several local, immunological and 
systemic factors play a role in RAS.
4-8
 As such, RAS 
may be an adverse effect of some medications.
9
 
Clinically, RAS is classified to three classes of minor, 
major, and herpetiform ulcers. Having less than 5mm 
diameter, minor RAS is the most common type, and 
happens in 80% of people. Whereas, the major form 
usually has a diameter of more than 1cm.
10,11
Treatment 
protocol depends on RAS type and symptoms. In this 
regard, the minor ulcers will relieve after applying 
topical NSAIDs (Nonsteroidal anti-inflammatory drug), 
corticosteroids or local anesthetics.
12,13
 
Myrtle is a perennial shrub widely distributed in the 
north of Iran. For many years, in Persian traditional 
medicine, Myrtle is known by its anti-hyperglycemic, 
antibacterial, anti-oxidant, anti-inflammatory and 
analgesic properties.
14-17
 These properties suggest 
potential efficacy of Myrtle in RAS treatment.
18
 Indeed, 
Myrtle paste is proven to be effective in decreasing size 
of ulcer, pain, severity and erythema.
19
 
Mucoadhesive drug delivery systems are preferred 
dosage forms for treatment of RAS ulcers because; the 
drug is targeted to a specific region and maintained there 
for a long period of time. Oral patches, in particular, are 
more favorable because of their ability to localize the 
drug and its effects.
20,21
 These formulations need to be 
resistant enough to maintain the integrity of drug 
delivery during jaw movement, and have to be flexible 
enough to avoid the interference with normal oral 
activity.
22,23
 
Several factors ought to be optimized for an appropriate 
oral patch. In this regard, experimental design is a 
statistical method providing the possibility of evaluation 
of several independent variables on a specific response 
with minimum number of conducted experiments. In 
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Abstract 
Purpose: Recurrent aphthous stomatitis (RAS) is the most common painful ulcerative 
disease of oral mucosa happening in ~20% of people. Aimed to develop Myrtus communis 
L. (Myrtle) containing oral patches, we applied box-behnken design to evaluate the effect of 
polymers such as Polyvinyl pyrrolidone (PVP), Gelatin, Methylcellulose (MC) and Pectin.  
Methods: The patches properties such as tensile strength, folding endurance, swelling 
index, thickness, mucoadhesive strength and the pattern of myrtle release were evaluated as 
dependent variables. Then, the model was adjusted according to the best fitted equation 
with box behnken design.  
Results: The results indicated that preparation of myrtle patch with hydrophilic polymers 
showed the disintegration time up to 24h and more. Using of polyvinyl pyrrolidone as a 
water soluble polymer and a pore-former polymer led to faster release of soluble materials 
from the patch to 29 (min-1). Also it decreases swelling index by increasing the patch 
disintegration. Gelatin and Pectin, with rigid matrix and water interaction properties, 
decreased the swelling ratio. Pectin increased the tensile strength, but gelatin produced an 
opposite effect. Thinner Myrtle patch (about 28µm) was obtained by formulation of methyl 
cellulose with equal ratio with polyvinyl pyrrolidone or gelatin. 
Conclusion: Altogether, the analysis showed that the optimal formulation was achieved 
with of 35.04 mg of Gelatin, 7.22 mg of Pectin, 7.20 mg of polyvinyl pyrrolidone, 50.52 mg 
of methyl cellulose and 20 mg of Myrtle extract.  
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particular, the effect of each independent variable is 
initially studied on a specific response. Subsequently, 
multiple regressions are performed to find the magnitude 
of effect (β) of each variable with respect to others. 
Finally, the interaction of independent variable was 
investigated to find possible synergy or antagonism. This 
method has been widely applied in numerous 
investigations to characterize and develop patch 
formulations.
24,25
 
In the current study, we aimed to optimize a patch 
formulation for Myrtle drug delivery by applying box-
behnken design.  
 
Materials and Methods 
Myrtle leaves were purchased from herbal medicine 
market, Yazd, Iran in January, 2015. The samples were 
authenticated at faculty of pharmacy, Shahid Sadoughi 
University of Medical Sciences, Yazd, Iran. Methyl 
cellulose (MC, MW: 658.73 g/mole), Gelatin (MW: 
180.16 g/mole), Pectin (PE, MW: 194.14 g/mole), 
Polyvinyl pyrrolidone (PVP, MW: 112.89 g/mole), 
Propylene glycol (PG) and Folin-Ciocalteu reagent were 
purchased from Sigma (USA). All reagents were of 
analytical grade. 
The leaves were powdered and then extraction was 
performed via percolation by Ethanol, 80% (v/v) at room 
temperature. Extraction was continued until no residual 
ingredient was observed in TLC (thin layer 
chromatography) followed by UV (ultra-violent) 
detection. Finally, the extracts were dried under vacuum 
evaporator and weighted to calculate the extractable 
material. Extraction efficiency was 12.5 percent. 
 
Determination of total phenol 
Total phenolic content of myrtle extract was determined 
in accordance with Folin–Ciocalteu method.26 Briefly, 
1.5 mL of Folin–Ciocalteu solution (diluted 10 times) 
was added to 200 μL of the diluted extract or gallic acid. 
They were mixed completely and placed at 22°C in water 
bath for 5 minutes. Then, 1.5 ml of sodium carbonate (60 
g.L
-1
) was added to test tubes, vortexed, and incubated at 
22°C in water bath for 90 minutes. Subsequently, 
absorption at 725 nm was determined using a UV-visible 
spectrophotometer (UNICO, 4802 double beam, Dayton, 
NJ, USA). Finally, the total phenolic content of the 
extracts were determined using a calibration curve with 
different concentrations of gallic acid (25, 50, 75, 100, 
125, 150 μg.mL-1). 
 
Preparation of muco-adhesive oral patches of Myrtle 
Different formulation of myrtle oral patches were 
prepared by solvent casting method.
27
 According to the 
Table 1, the proper amounts of each polymer was 
dispersed in deionized water and mixed for 24 h. Then, 
20 mg of myrtle extract was diluted in 1ml of water, 
added to other ingredient, and mixed. Subsequently, 
proper amounts of PG, as plasticizer, were added to 
above mixture, and homogenized for 2 h. The total 
mixture was, then, degassed using a desiccator connected 
with vacuum pump for 6h. Finally, each formulation was 
casted in petri dish (diameter of 35 mm), and kept for 
48h to dry. 
 
Table 1. The high and low levels of independent variables 
 Independent variables -1 Level +1 Level 
A Gelatin 1 25 
B Pectin 5 25 
C Polyvinyl pyrrolidone 5 25 
D Methylcellulose 25 75 
 
Surface pH 
Surface pH of the myrtle patches was determined with 
agar plate as described by Bottenberg et al.
28
 Briefly, 
agar solution 2% (w/v) was prepared by mixing the 
required agar in water and then dispersed in simulated 
saliva (pH: 6.2). After solidification of agar and 
simulated salvia, the patches were placed on the surface 
of agar plate and allowed to swell for 2h. The surface pH 
finally determined by pH indicator strip. All 
measurements were carried out in triplicate. 
 
Thickness, folding endurance and tensile strength  
Screw gauge (model: 3D CAD) was employed to obtain 
the thickness of patches with a precision of 0.01 mm. 
The thickness was measured at different points and the 
average value was recorded.
10
 
The folding endurance of patches was evaluated with 
continuous folding/re-folding episodes. According to the 
previous investigations, the suitable patch is defined as 
the one enduring more than 200 sequential 
folding/refolding challenges.
29
 
The consistency of patches was evaluated using a 
tensilometer. In brief, a 2×1cm strip of patch was 
attached to two jaws; one of the jaws was fixed and the 
other was moving. The tensile strength was determined 
as resistance against breaking apart when the strip was 
pulled with increments of weight in moving jaw. The 
dial number was recorded as the tensile strength of the 
patch with unit of N/cm. 
 
Swelling study 
The swelling ratio was measured by placing the patches 
on the surface of 2% agar plates. Agar plates were, then, 
incubated at 37°C, and the patches were weighed at 5, 
10, 60, and 120 min after incubation. Finally, the 
swelling index was calculated as: Swelling index (%) = 
[(Wt – W0) / W0] ×100; Where, W0 is the initial weight, 
and Wt is the weight of swelled patch after the incubation 
for time t. 
 
Ex vivo mucoadhesive strength 
The mucoadhesive strength of films were investigated 
using a modified physically balanced instrument 
described by Gupta.
30
 In brief, the patch was placed 
between two parallel surfaces covered with buccal 
mucosa. The film was allowed for a while to stick to the 
buccal surfaces. While one of the surfaces remained 
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constant, the other moved in response to increments of 
weight applied. Accordingly, the maximum required 
force to detach the buccal surfaces was measured by an 
accurate digital dynamometer. The buccal area was 2.4 
cm
2
 and muco-adhesive strength of the films was 
reported in N/cm
2
scale. 
 
In vitro release study 
USP apparatus Type-2 rotating paddle (Erweka, 
Germany) was used to evaluate the release of myrtle 
extract from patches. Dissolution was performed in 500 
mL of phosphate buffer (pH: 6.8) at 37±1°C and 
continuous stirring at 50 r/min.
31
 The patches (3×3 cm) 
were floated in dissolution medium and 2ml of medium 
was extracted at different time intervals. Finally, Total 
phenol of each sample was analyzed and the rate of 
release was determined by modeling of the release 
pattern using regression with suitable R
2
. 
 
Statistical design 
A box behnken method was applied to design, analyze, 
and optimize the myrtle patches. The concentration of 
gelatin, pectin, PVP, and methyl cellulose was selected 
as independent variables (Table 1). Accordingly, 
bioadhesion, patch thickness, the rate of polyphenol 
release, and swelling index were examined as dependent 
variables. Taken together, a total of 29 runs with 5 center 
points were designed and conducted (Table 2). The 
results were analyzed with model fitting based on 
ANOVA test, and P values< 0.05 were considered as 
significant. 
 
Results and Discussion 
Different parts of myrtle are rich in polyphenolic 
compounds such as phenolic acids, tannins, and 
flavonoids explaining its antiseptic effects.
32
 Myrtle 
phenolic compounds are highly soluble in media 
resembling saliva. Therefore, the retention time of myrtle 
ingredients on aphthous ulcers is extremely low when is 
formulated in aqueous form.
33
 Considering the chronic 
and recurrent nature of these ulcers, mucoadhesive 
patches seem appropriate to increase the drug exposure 
time and, hence, treatment efficiency.  
In this investigation, a box behnken design was applied 
to develop an efficient mucoadhesive myrtle patch. As 
summarized in Table 2, the effect of several variables 
was studied in total of 29 formulations with different 
polymer combinations. At first, screening was performed 
to find the most critical factors. In this step, the 
concentration of myrtle, as active ingredient, and PG, as 
plasticizer, were considered as constant. The screening 
outcomes clarified methyl cellulose as the cornerstone 
polymer. Therefore, the ratio of other polymers was 
determined based on this polymer.  
 
Thickness of the patch 
the prepared films were uniform in thickness with 
smooth surface. The films thickness in different 
formulations was in the range of 27.60 to 38.30 μm 
(Table 3). Furthermore, a modified quadratic model with 
the following equation was fitted on the data (p: 0.0004); 
thickness of ptach =+28.58-
0.56*A+0.73*B+0.11*C+1.07*D-3.07*A*D-
1.30*C*D+1.58*A2+1.11*C2+1.84*D2; where, A, B, C, 
and D are gela\ 
in, pectin, PVP, and MC, respectively. Indeed, MC (β: 
+1.07, p: 0.014) was the main determining factore for the 
patch thickness. That is, the more the ratio of MC, the 
thicker the final patch. Also, there were a significant 
interaction between MC and Gelatin (p: 0.0003). In this 
regard, the minimum thickness was obtained with 
combination of gelatin or PVP with the ratio of 1:1 
(Figure 1). The thickness of film is essential factor in 
interaction of film with biological and patients 
compliance. As it was shown, the film thicness is 
affected by methyl cellullse as a film former agent. In 
parallel, Esmaeili A et al, showed that the thickness of 
methyl cellulose film is dependent on the ratio of film 
former and other additives.
34
 Also it can be affected by 
the interaction of other polymers with MC in the film.
35
 
 
Table 2. Design of experiment in case of 29 runs according to 
box-behnken design 
Runs Gelatin Pectin polyvinyl pyrrolidone Methylcellulose 
1 1 1 0 0 
2 1 0 0 1 
3 0 -1 1 0 
4 0 0 0 0 
5 1 0 0 -1 
6 -1 0 0 1 
7 0 0 0 0 
8 1 0 -1 0 
9 0 0 0 0 
10 1 -1 0 0 
11 0 0 -1 1 
12 0 -1 0 1 
13 -1 0 0 -1 
14 1 0 1 0 
15 0 -1 0 -1 
16 0 1 -1 0 
17 -1 1 0 0 
18 0 0 0 0 
19 0 1 0 -1 
20 0 0 1 1 
21 0 -1 -1 0 
22 -1 -1 0 0 
23 0 0 0 0 
24 0 0 1 -1 
25 -1 0 -1 0 
26 -1 0 1 0 
27 0 1 1 0 
28 0 1 0 1 
29 0 0 -1 -1 
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Table 3. The magnitude of various responses for all formulations 
 
Mucoadhesiveness 
(N/cm
2
) 
Release rate 
(min
-1
) 
Swelling ratio 
(%) 
Thickness 
(µm) 
Tensile strength 
(N/cm) 
Disintegration 
time 
F1 
F2 
125 
75 
37.87 
39.04 
222.8 
256.8 
30.3 
31 
295 
225 
10h 
9h 
11h 
10h 
4h 
>24h 
10h 
3h 
>24h 
10h 
>24h 
9h 
8h 
3h 
3h 
8h 
>24h 
10h 
9h 
6h 
6h 
11h 
6h 
6h 
12h 
10h 
9h 
6h 
4h 
F3 
F4 
F5 
F6 
F7 
F8 
F9 
F10 
F11 
F12 
F13 
F14 
F15 
F16 
F17 
F18 
F19 
F20 
F21 
F22 
F23 
F24 
F25 
F26 
F27 
F28 
F29 
200 
140 
130 
160 
120 
110 
140 
140 
100 
120 
135 
120 
180 
175 
190 
130 
125 
135 
210 
165 
180 
150 
180 
210 
155 
90 
195 
35.8 
37.26 
38.07 
35.33 
35.51 
27.5 
37.22 
33.44 
33.57 
36.35 
36.3 
39.26 
38.92 
36 
36.92 
38.37 
37.96 
39.38 
35 
41.17 
38.16 
39.88 
36.45 
38.84 
37.37 
39.52 
29.1 
209.9 
189.3 
276.6 
136.4 
238 
260.3 
240.7 
272.6 
259.7 
175 
167.6 
206.4 
215 
214.9 
192.7 
205 
198.4 
195.5 
195.6 
131.9 
220.8 
316.9 
192.4 
208 
229.4 
241.3 
210.6 
29.3 
29 
33.3 
38.3 
30.3 
29.6 
29.3 
28.6 
35.3 
30 
28.3 
30.7 
28.3 
29 
31.3 
28 
30.3 
30 
29 
29.6 
27.6 
30.6 
30.7 
32 
33 
29.7 
30.7 
400 
355 
215 
695 
345 
230 
500 
345 
550 
200 
695 
360 
170 
435 
755 
355 
445 
460 
335 
705 
610 
660 
605 
560 
715 
1175 
580 
 
 
 
Figure 1. The interaction between Methyl cellulose and gelatin (A) and Methyl cellulose and Polyvinyl pyrrolidone (B) on thickness of 
patch. acording to figure, the minimum thickness can obtain with combination of gelatin or Polyvinyl pyrrolidone with the ratio of 1:1. 
 
Tensile strength 
As summarized in Table 3, the type of polymer played a 
crucial role in film resistance against breaking apart. A 
modified quadratic model with the following equation 
was fitted to the tensile strength data; tensile strenght 
=+424.57-195.42*A+93.58*B+35.00*C-
0.17*D+53.75*BC+310.50 * BD-42.50 * CD+85.92 * 
B
2
+97.79 * D
2
; where, A, B, C, and D are gelatin, pectin, 
PVP, and MC, respectively. Indeed, gelatin with negative 
and pectin with positive coefficients significantly 
influenced the patch consistency. Furthermore, 
augmentation of MC with pectin resulted in dramatic 
increase in tensile strength (Figure 2). The data were in 
agreement with El Halal SL
36
 and Dogan N
37
 studies that 
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showed the addition of cellulose resulted in increase in 
total strength of edible film. Also pectin is known as a 
rigid polymer
38
 and need to modifications with different 
material to use in the films. This indicates that 
polysaccharides play a pivotal role in tensile endurance. 
In this regard, the hydroxyl groups in the structure of 
polysaccharides provide the possibility of hydrogen bond 
formation.
39
 Accordingly, polymer chain cross linking as 
well as polymer interaction with myrtle ingredients 
results in a stronger matrix.
40
 In addition, pectin, a 
complex polysaccharide, produces hydrogen and non-
covalent bonds with cellulose, and acts as a binder. 
Therefore, pectin and cellulose synergistically increase 
the tensile strength. This explains why formulations 
containing these excipients exhibited maximal endurance 
against physical tension.
41
 
Data analysis showed that there was no correlation 
between the tensile strength and thickness of patches. It 
showed that the containing polymer and polymer chain 
interactions determined the tensile strength of patch and 
polymer amount has minimal effect on this property. 
 
 
Figure 2. The interaction between Methyl cellulose and pectin on 
tensile of patch. according tothe Figure the interaction of Methyl 
cellulose and pectin content in formulation resulted in dramatic 
increase in patch tensile strength. 
 
Swelling ratio and surface pH  
Polymers with pK equal to that of extract helped develop 
films with narrow range of neutral surface pH (7-7.4) in 
all formulations that is suitable for oral ulcer which is 
sensitive to extreme acidic or basic condition and also it 
is suitable for oral application without mucosal 
irritation.
42
 
Swelling behavior plays a pivotal role in the pattern of 
drug release as well as the mucoadhesiveness of patch.
43
 
It depends on several factors such as the 
physicochemical properties of the ingredients. Indeed, 
water solubility and wet ability of polymers determines 
the ability of water absorption. Accordingly, matrix 
integrity and disintegration rate defines the final 
extension of patch.
43
 This indicates that the type and ratio 
of polymers determine the swelling index and, 
subsequently, the rate and pattern of drug release and 
bio-adhesiveness.  
The swelling ratio in formulations varied from 131.90% 
to 316.90%.As such, different formulations exhibitted 
distinct patterns of swelling (Figure 3). Overal, a 2FI vs 
Linear model was fitted on the data (p: 0.0002); Swelling 
index =+216.57+38.88*A+8.29*B+2.72*C-10.03*D-
27.65*A*B-42.63*C*D; where, A, B, C, and D are 
gelatin, pectin, PVP, and MC, respectively. This 
indicates that gelatin (β: +38.88) was the most crucial 
factor for swelling compared to other polymers. That is, 
the more the ratio of gelatin in formulation, the higher 
the swelling index of the resulted patch. Also, there was 
an interaction between glatin and pectin (p:0.0439). also 
there was an interaction between MC and PVP (p: 
0.0033). In particular, maximum swelling index was 
observed in formulations containing maximum ratio of 
gelatin and minimum ratio of pectin. On the other hand, 
formulations containing equal amounts of PVP and MC 
exhibitted the lowest swelling index (Figure 4). 
 
 
Figure 3. The swelling pattern of selected formulations (run 5 : 
31.3% gelatin, 18.8 % pectin, 18.8% polyvinyl pyrrolidone, 31.3 
% Methyl cellulose; run 22 : 1.4 % gelatin, 7 % pectin, 21.1 % 
polyvinyl pyrrolidone, 70.5 % Methyl cellulose; run 24 : 16.7 % 
gelatin, 19.2 % pectin, 32.1 % polyvinyl pyrrolidone, 32.1 % 
Methyl cellulose; run 28 10.2 % gelatin, 19.5 % pectin, 11.7 % 
polyvinyl pyrrolidone, 58.6 % Methyl cellulose).  
 
Hydrophilic groups such as –OH, -COOH and –NH2 in 
gelatin structure provides the possibility of hydrogen 
bond formation, and thereby high water absorption. This 
explains the positive impact of gelatin on swelling index. 
In this regard, the swelling index of gelatin depends on 
ionization of the functional groups. Therefore, the 
medium pH as well as electrolyte concentration and 
presence of other complexing agents influence the 
ionization state of gelatin.
44
 This highlights the 
importance of other factors in gelatin-induced alteration 
of swelling index. In fact, formulations containing pectin 
and gelatin demonstrated lower swelling ratio compared 
to those containing only gelatin. This may be explained 
by the fact that pectin, with lots of -COOH group, 
interferes with –NH2 groups in gelatin, thereby, 
decreases the capacity of gelatin for hydrogen bond 
formation and water absorption. In this regard, Mishara 
et al showed that increasing the ratio of gelatin in the 
pectin film enhanced the swelling index by improving 
the film porosity.
44
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PVP, by itself, didn’t have any significant effect on 
swelling index. However, it did decrease the swelling 
ratio of patches containing MC (β: -42.63). This seems 
contrary to the high aqueous solubility of PVP which can 
enhance the wet ability and water absorption and 
disintegration rate of the hydrophilic matrix. In this 
regard, PVP enhanced the swelling of chitosan films, an 
insoluble polymer.
43
 whereas no portion of highly 
soluble polymers such as HPMC lead to increasing the 
swelling of patch.
45
 
 
 
Figure 4. The interaction between pectin and gelatin (A) and Methyl cellulose and Polyvinyl pyrrolidone (B) on swelling of patch. 
According to figure, the maximum swelling index is approachable with maximum ratio of gelatin vs minimum ratio of pectin in formulation. 
On the other hand, there is the lowest swelling ratio when Polyvinyl pyrrolidone and Methyl cellulose are employed equally in the 
formuation. 
 
Mucoadhesiveness test 
We observed that gelatin (β: -25), MC (β: -19), and 
pectin (β: -12) were main factor influencing 
mucoadhesiveness of the patches. The result showed that 
the mucoadhesiveness of the myrtle patches was 
acceptable when polymers are used in low concentration. 
One of the most important factors affecting 
mucoadhesion is the concentration of polymers. Higher 
level of polymers is responsible for forming highly 
coiled structure of the polymers which can reduce the 
polymer chains flexibility and interaction with mucin. 
Subsequently, the mucoadhesion force will fall under 
acceptable value.
46
 Namely, Malik and his coworkers 
indicated that increasing the concentration of chitosan in 
the ondansetron loaded beads will decrease the 
mucoadhesion force.
47
 In this regard, the data best fitted 
to the following equation; mucoadhesiveness =+138.24-
25.00*A-12.92*B+3.33*C-19.58*D- 
20.00*A*D+20.00*C*D+17.18*B
2
+20.30*C
2
–
17.82*D
2
; where, A, B, C, and D are gelatin, pectin, 
PVP, and MC, respectively. This indicates a synergistic 
effect between PVP and MC (β: +20). 
Mucin in the structure of buccal surface is negatively 
charged. Therefore, positively charged excipients in 
formulation ought to enhance bioadhesion. In particular, 
high molecular weight polymers such as pectin as well as 
insoluble ones like chitosan produce stronger interactions 
with mucin.
48
 However, we found that pectin had a 
negative impact on bioadhesion (β: -12). As such, 
positively charged PVP did not significantly alter this 
parameter (β: +3.33, p> 0.05). This observation is 
supported by Jiyeon and coworkers. They designed a 
bilayer mucoadhesive strip of lidocaine and showed that 
PVP was not able to enhance mucoadhesivity. However, 
they showed that addition of HPMC to the bilayer strips 
increased the mucoadhesion strength.
49
 This indicates 
that bioadhesion is not determined only with surface 
charge density. In fact, several factors come to play 
including surface charge density, flexibility, polymer 
molecular weight, swelling rate, type of the biological 
surface to which the patch is adhered and the adherence 
time.
43
 For instance, polymers enhancing the swelling 
index seem to reduce bioadhesion. In this regard, gelatin 
(β: +38.88) and MC (β: +10.03) significantly enhanced 
swelling index. In contrast, they had an inverse effect on 
bioadhesion (β: -25 and -19.58 for gelatin and MC, 
respectively). In this regard, patches produced with 
chitosan matrix having gelatin displayed less 
mucoadhesive strength compared to those having only 
chitosan.
50
 
 
Myrtle release of patch 
According to Table 3, almost the formulations composed 
the myrthys with long perod of disintegration time up to 
more than 24 houre in some formulations. Howevere 
polyphenolic compound was released of formulation 
between 3 to 6 houres. 
Overal, the release rate best fitted to the following 
model; release rate =+37.49-
0.82*A+0.41*B+2.74*C+2.17*A*B+2.34*A*C-
1.82*C
2
; where, A, B, C, and D are gelatin, pectin, PVP, 
and MC, respectively. This indicates PVP as the main 
factor determining polyphenol release from the patch. In 
fact, there was a positive correlation between the ratio of 
this cationic polymer and the rate of myrtle release from 
the patch (β: +2.74, F-value: 23.68).  
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Polyphenols are among water soluble materials. 
Therefore, their release from the matrix ought to have a 
direct relationship with the capacity of patch to absorb 
water. In this regard, water soluble polymers such as 
PVP enhance water absorption, promotes the drug 
release and patch dissolution. In addition, PVP as a pore-
former polymer creates lots of water channels, and cause 
perturbation of the matrix consistency. Subsequently, 
these channels allow better water penetration, swelling 
and ultimately faster drug diffusion.
51
 Similarly, PVP is 
shown to enhance the release of soluble drugs such as 
sumatriptan succinate and felodipine from polymeric 
matrix.
52,53
 
In contrast, other polymers did not influence polyphenol 
release by themselves, although their effect was 
significant when used in combination. In this regard, co-
formulation of gelatin and pectin (β: +2.17) as well as 
gelatin and PVP (β: +2.34) enhanced polyphenol release 
from the patch. Similarly, it was observed that gelatin 
concentration solely, does not play a crucial role in 
release of bupivacaine.
54
 The failure of gelatin and MC, 
highly water soluble polymers, to influence drug release 
may seem contrary to the above mentioned direct 
relationship between the water solubility of polymer and 
drug release. This suggests a potential role for other 
factors. For instance, the composition of patch may 
influence the disintegration rate via mechanical 
properties of sol-gel interface with water.
55
 In addition, 
total patch weight influenced the release rate (Figure 5). 
As such, solid content in the patch is another factor that 
can delay the extract release.
56
 In fact, higher solid 
content diminishes matrix porosity, thereby inhibiting 
water penetration and outward movement of drug from 
matrix.
55
 In this regard, increase in pectin and gelatin 
concentration delayed polyphenol release from the 
matrix (Figure 5A). Similarly, Ikram and coworkers 
showed that the release of drug from the matrix is 
dependent on the polymer properties and specially the 
viscosity of the polymeric matrix after water diffusion 
inside. Also the immobile water in the matrix by 
increasing the swelling index, create the new condition 
for drug release. All together the total tendency of 
polymer to water absorption and the ratio of patch 
swelling as well as polymer viscosity will identify the 
fate of drug release.
57
 So the higher content of gelatin in 
combination with PVP or pectin in the myrtle patches, 
with high water absorption and swelling index, leads to 
increase the rate of drug release. However, optimization 
of the ingredients is necessary to obtain the patch with 
desire release rate.  
 
 
Figure 5. The interaction between Polyvinyl pyrrolidone and gelatin (A) and pectin and gelatin (B) on release myrtle from patch. 
According to the Figure, the correlation between the weight of patch and drug release. It shows that the amount of solid content in the 
patch is another factor that can delay the extract release. 
 
Optimization 
According to the optimal value for each response, the 
best formulation was predetermined. In fact, the ratio of 
each excipient was predicted to result in the desired 
response. Then, the final formulation was determined to 
get a patch with optimal values in all responses (Table 
4). The calculated optimal formulation was composed of 
PVP, MC, pectin, gelatin and myrtle extract with ratios 
of 1:13:1:5:3, respectively.  
 
Table 4. Predicted value of optimum formulation 
 Gelatin Pectin 
Polyvinyl  
pyrrolidone 
Methylcellulose 
Release rate 
(min
-1
) 
Swelling ratio 
(%) 
Thickness 
(µm) 
Desirability 
Predicted value 25 5 5 65 27.5 291.9 30.0 0.92 
 
The final patch was produced with the predicted ratios 
for optimal formulation. Then, dependent variables were 
studied once again for the final patch. The results 
demonstrated good agreement between the predicted and 
observed responses. 
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Conclusion 
The suitable oral patch of myrtus communis L. can 
develop with the aid of soluble polymer including 
polyvinyl pyrrolidone, gelatin, pectin and methyl 
cellulose. Inclusion of gelatin in myrtus patches helps to 
higher swelling and hydration but with negative effect on 
mucuadhesive property. Pectin same as gelatin compose 
of oral patch with higher tensile strange. The release of 
myrtus extract is depended on water solubility of 
polymer. And, PVP as a low molecular water soluble 
polymer make the extract release faster. Altogether, 
optimization of the hydrophilic polymer in the patch, 
made it so flexible with degradation time more than 24 h 
and release rate of 27.5 (min
-1
) and swelling ratio of 
about 300%. 
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